Adrian Newman-Tancredi
is also co-founder and
Chief Scientific Officer
of
Neurolixis Inc.

 

News

Adrian Newman-Tancredi is PI of a supplementary research grant that has been awarded by The Michael J. Fox Foundation for Parkinson's Research (MJFF) to Neurolixis Inc. Adrian is...Read More
Alzheimer disease is associated with profound changes in neurotransmitter regulation in the brain. The hippocampus is one brain region that regulates memory and serotonin 5-HT1A...Read More
Adrian Newman-Tancredi will be chairing a session at an online neuroscience conference taking place from 17th to 19th June 2014. The webinar, organized by the online life-science...Read More

NeuroAct Communication offers independent consulting in neuropharmacology and preclinical drug discovery to
bioscience companies, agencies and the investment community.